全文获取类型
收费全文 | 851篇 |
免费 | 76篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 44篇 |
妇产科学 | 7篇 |
基础医学 | 125篇 |
口腔科学 | 10篇 |
临床医学 | 104篇 |
内科学 | 152篇 |
皮肤病学 | 19篇 |
神经病学 | 74篇 |
特种医学 | 158篇 |
外科学 | 92篇 |
综合类 | 13篇 |
预防医学 | 58篇 |
眼科学 | 18篇 |
药学 | 41篇 |
1篇 | |
中国医学 | 2篇 |
肿瘤学 | 17篇 |
出版年
2023年 | 3篇 |
2022年 | 5篇 |
2021年 | 8篇 |
2020年 | 9篇 |
2019年 | 6篇 |
2018年 | 13篇 |
2017年 | 9篇 |
2016年 | 10篇 |
2015年 | 13篇 |
2014年 | 10篇 |
2013年 | 26篇 |
2012年 | 35篇 |
2011年 | 44篇 |
2010年 | 15篇 |
2009年 | 21篇 |
2008年 | 27篇 |
2007年 | 44篇 |
2006年 | 37篇 |
2005年 | 31篇 |
2004年 | 30篇 |
2003年 | 31篇 |
2002年 | 22篇 |
2001年 | 26篇 |
2000年 | 22篇 |
1999年 | 30篇 |
1998年 | 26篇 |
1997年 | 17篇 |
1996年 | 29篇 |
1995年 | 18篇 |
1994年 | 27篇 |
1993年 | 18篇 |
1992年 | 16篇 |
1991年 | 19篇 |
1990年 | 12篇 |
1989年 | 31篇 |
1988年 | 22篇 |
1987年 | 29篇 |
1986年 | 15篇 |
1985年 | 14篇 |
1984年 | 15篇 |
1983年 | 16篇 |
1982年 | 11篇 |
1981年 | 15篇 |
1980年 | 13篇 |
1979年 | 9篇 |
1977年 | 6篇 |
1976年 | 9篇 |
1974年 | 3篇 |
1970年 | 4篇 |
1969年 | 3篇 |
排序方式: 共有937条查询结果,搜索用时 0 毫秒
21.
22.
First Report of Ceftazidime-Avibactam Resistance in a KPC-3-Expressing Klebsiella pneumoniae Isolate
Romney M. Humphries Shangxin Yang Peera Hemarajata Kevin W. Ward Janet A. Hindler Shelley A. Miller Aric Gregson 《Antimicrobial agents and chemotherapy》2015,59(10):6605-6607
Ceftazidime-avibactam is the first antimicrobial approved by the U.S. FDA for the treatment of carbapenem-resistant Enterobacteriaceae. Avibactam, a non-β-lactam β-lactamase inhibitor, inactivates class A serine carbapenemases, including Klebsiella pneumoniae carbapenemase (KPC). We report a KPC-producing K. pneumoniae isolate resistant to ceftazidime-avibactam (MIC, 32/4 μg/ml) from a patient with no prior treatment with ceftazidime-avibactam. 相似文献
23.
ILR Genetics Consortium Emerging Risk Factors Collaboration Sarwar N Butterworth AS Freitag DF Gregson J Willeit P Gorman DN Gao P Saleheen D Rendon A Nelson CP Braund PS Hall AS Chasman DI Tybjærg-Hansen A Chambers JC Benjamin EJ Franks PW Clarke R Wilde AA Trip MD Steri M Witteman JC Qi L van der Schoot CE de Faire U Erdmann J Stringham HM Koenig W Rader DJ Melzer D Reich D Psaty BM Kleber ME Panagiotakos DB Willeit J Wennberg P Woodward M Adamovic S Rimm EB Meade TW Gillum RF Shaffer JA 《Lancet》2012,379(9822):1205-1213
24.
A. Derhovanessian M. Y. Shino W. A. Davis L. D. Snyder A. L. Gregson R. Saggar J. P. Lynch III D. J. Ross A. Ardehali R. M. Elashoff J. A. Belperio 《American journal of transplantation》2013,13(4):919-927
Aspergillus colonization after lung transplantation may increase the risk for bronchiolitis obliterans syndrome (BOS), a disease of small airways. We hypothesized that colonization with small conidia Aspergillus species would be associated with a greater risk of BOS, based upon an increased likelihood of deposition in small airways. We studied adult primary lung recipients from two large centers; 298 recipients at University of California, Los Angeles and 482 recipients at Duke University Medical Center. We grouped Aspergillus species by conidia diameter ≤3.5 μm. We assessed the relationship of colonization with outcomes in Cox models. Pre‐BOS colonization with small conidia Aspergillus species, but not large, was a risk factor for BOS (p = 0.002, HR 1.44, 95% CI 1.14–1.82), along with acute rejection, single lung and Pseudomonas. Colonization with small conidia species also associated with risk of death (p = 0.03, HR 1.30, 95% CI 1.03–1.64). Although other virulence traits besides conidia size may be important, we have demonstrated in two large independent cohorts that colonization with small conidia Aspergillus species increases the risk of BOS and death. Prospective evaluation of strategies to prevent Aspergillus colonization of small airways is warranted, with the goal of preserving lung allograft function as long as possible. 相似文献
25.
26.
The Role of TGF‐β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome
下载免费PDF全文
![点击此处可从《American journal of transplantation》网站下载免费的PDF全文](/ch/ext_images/free.gif)
A. DerHovanessian S. S. Weigt V. Palchevskiy M. Y. Shino D. M. Sayah A. L. Gregson P. W. Noble S. M. Palmer M. C. Fishbein B. M. Kubak A. Ardehali D. J. Ross R. Saggar J. P. Lynch III R. M. Elashoff J. A. Belperio 《American journal of transplantation》2016,16(2):640-649
Primary graft dysfunction (PGD) is a possible risk factor for bronchiolitis obliterans syndrome (BOS) following lung transplantation; however, the mechanism for any such association is poorly understood. Based on the association of TGF‐β with acute and chronic inflammatory disorders, we hypothesized that it might play a role in the continuum between PGD and BOS. Thus, the association between PGD and BOS was assessed in a single‐center cohort of lung transplant recipients. Bronchoalveolar lavage fluid concentrations of TGF‐β and procollagen collected within 24 h of transplantation were compared across the spectrum of PGD, and incorporated into Cox models of BOS. Immunohistochemistry localized expression of TGF‐β and its receptor in early lung biopsies posttransplant. We found an association between PGD and BOS in both bilateral and single lung recipients with a hazard ratio of 3.07 (95% CI 1.76–5.38) for the most severe form of PGD. TGF‐β and procollagen concentrations were elevated during PGD (p < 0.01), and associated with increased rates of BOS. Expression of TGF‐β and its receptor localized to allograft infiltrating mononuclear and stromal cells, and the airway epithelium. These findings validate the association between PGD and the subsequent development of BOS, and suggest that this association may be mediated by receptor/TGF‐β biology. 相似文献
27.
M. H. F. Poorthuis R. Bulbulia D. R. Morris H. Pan P. M. Rothwell A. Algra J.-P. Becquemin L. H. Bonati T. G. Brott M. M. Brown D. Calvet H.-H. Eckstein G. Fraedrich J. Gregson J. P. Greving J. Hendrikse G. Howard O. Jansen J.-L. Mas S. C. Lewis G. J. de Borst A. Halliday the Carotid Stenosis Trialists' Collaboration 《The British journal of surgery》2020,107(6):662-668
28.
The amino acid intermediate homocysteine (Hcy) is formed during the metabolism of methionine to cysteine. Hyperhomocysteinemia (HHcy) is recognized as an independent risk factor for coronary atherosclerosis. The circulating levels of total Hcy (tHcy) can increase due to intake of foods rich in methionine or deficiencies of vitamins such as folate, pyridoxine and cyanocobalamin, which are required for the metabolism of Hcy. In addition, mutations in the genes coding for Hcy metabolizing enzymes can contribute to an increase in tHcy levels. Clinical and epidemiological studies have shown that an elevated level of tHcy measured in serum or plasma is a strong predictor of cardiovascular disease risk, which appears to be greatest in patients who have HHcy following a methionine load. Intimal hyperplasia (IH) (intima/media [I/M] ratio) is the universal response of a vessel to injury and may result in vasoconstriction when left unattended. The effect of dietary HHcy on balloon catheter-injured carotid artery and its modulation (if any) by the peroxisome proliferator-activated receptor agonist gamma rosiglitazone was evaluated in 12-week-old female Sprague-Dawley rats fed either a control diet or a diet containing 1% L-methionine. Once the rats were established on the diet, the group that was fed 1% L-methionine was further subdivided and either given an aqueous preparation of 3 mg/kg/day rosiglitazone or the vehicle via oral gavage for one week. This was followed by surgically injuring the left carotid artery using a Maverick Over-The-Wire catheter (2.0 mm × 20 mm, 3.2F; Boston Scientific, USA). The rats were continued on their respective diets and drug regimen for 21 days postsurgery. On day 22 of the procedure, the rats were sacrificed for collection of blood, the carotid arteries and liver for biochemical and histological evaluation. Compared with controls there was a significant increase in both tHcy levels and I/M ratio in the rats fed 1% L-methionine (5.4±0.28 μM versus 32.8±3.01 μM, P<0.002; and 0.175±0.05 versus 1.05±0.23, P<0.005, respectively). The effect of rosiglitazone in rats fed the control diet was not prominent. On the other hand, administration of rosiglitazone to the rats on the 1% L-methionine diet significantly reduced the levels of serum tHcy (16.6±2.1 μM versus 32.8±3.01 μM, P<0.001); however, the tHcy levels remained significantly elevated compared with animals on the control diet (P<0.002). The group receiving the L-methionine diet plus rosiglitazone had an inhibition in the development of IH compared with those receiving the L-methionine diet alone (I/M of 0.278±0.041 versus 1.05±0.23, P<0.01). Moreover, the development of IH in the group receiving the L-methionine diet plus rosiglitazone treatment was not significantly different from that observed in the group on the control diet without rosiglitazone (0.278±0.041 versus 0.175±0.05, respectively). These findings may have important implications in deciphering the molecular mechanisms involved in the augmentation of IH in HHcy and modulation of this process by rosiglitazone. 相似文献
29.
30.
[目的]调查产后抑郁症患者的现状及需求,探讨预防措施。[方法]定性与定量研究相结合,定性采用专题小组讨论和半结构性访谈,12人参加专题讨论、9人半结构性访谈;定量研究随机抽取本市各社区产后42d的产妇776例行问卷调查。[结果]产妇月子期间常发生头疼、恶心、焦虑、恐惧、失眠以及照顾新生儿困难;半结构性访谈中有1产妇处于产后抑郁症的临界,EPDS量表测定为12分;776例产妇月子里有身心健康问题者692例,求助者91.0%,其中需要社区护理人员帮助的71.7%,实际寻求帮助仅12.7%。[结论]预防产后抑郁症应实行社区医护人员培训与产后访视人员的准入制度,采取社区医护干预的三级预防,同时拓展社区产后保健服务的内涵。 相似文献